SABBY ARWR 13G 08.16.12

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

August 16, 2012

Accession Number

0001535610-12-000014

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →